Shay Gur

Construct Measurement and Validation Procedures in MIS and Behavioral Research: Integrating New and Existing Techniques1

Management of sexual dysfunction due to antipsychotic drug therapy

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Examination of the known-groups validity of the Liebowitz Social Anxiety Scale

Descending control of pain

Network pharmacology: the next paradigm in drug discovery

The Impact of Mental Illness on Sexual Dysfunction

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.

Mutations in theCaenorhabditis elegansSerotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine

MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Mianserin, a 5-HT2a/2c and α2 Antagonist, in the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors

Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew